Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether milrinone can optimize cerebral hemodynamics to prevent delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milrinone (milrinone)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: RECRUITING